Literature DB >> 26166134

Development and Validation of an in vitro Experimental GastroIntestinal Dialysis Model with Colon Phase to Study the Availability and Colonic Metabolisation of Polyphenolic Compounds.

Annelies Breynaert1, Douwina Bosscher1, Ariane Kahnt2, Magda Claeys2, Paul Cos3, Luc Pieters4, Nina Hermans1.   

Abstract

The biological effects of polyphenols depend on their mechanism of action in the body. This is affected by bioconversion by colon microbiota and absorption of colonic metabolites. We developed and validated an in vitro continuous flow dialysis model with colon phase (GastroIntestinal dialysis model with colon phase) to study the gastrointestinal metabolism and absorption of phenolic food constituents. Chlorogenic acid was used as model compound. The physiological conditions during gastrointestinal digestion were mimicked. A continuous flow dialysis system simulated the one-way absorption by passive diffusion from lumen to mucosa. The colon phase was developed using pooled faecal suspensions. Several methodological aspects including implementation of an anaerobic environment, adapted Wilkins Chalgren broth medium, 1.10(8) CFU/mL bacteria suspension as inoculum, pH adaptation to 5.8 and implementation of the dialysis system were conducted. Validation of the GastroIntestinal dialysis model with colon phase system showed a good recovery and precision (CV < 16 %). Availability of chlorogenic acid in the small intestinal phase (37 ± 3 %) of the GastroIntestinal dialysis model with colon phase is comparable with in vivo studies on ileostomy patients. In the colon phase, the human faecal microbiota deconjugated chlorogenic acid to caffeic acid, 3,4-dihydroxyphenyl propionic acid, 4-hydroxybenzoic acid, 3- or 4-hydroxyphenyl acetic acid, 2-methoxy-4-methylphenol and 3-phenylpropionic acid. The GastroIntestinal dialysis model with colon phase is a new, reliable gastrointestinal simulation system. It permits a fast and easy way to predict the availability of complex secondary metabolites, and to detect metabolites in an early stage after digestion. Isolation and identification of these metabolites may be used as references for in vivo bioavailability experiments and for investigating their bioactivity in in vitro experiments. Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26166134     DOI: 10.1055/s-0035-1546154

Source DB:  PubMed          Journal:  Planta Med        ISSN: 0032-0943            Impact factor:   3.352


  4 in total

1.  Availability and Metabolic Fate of Olive Phenolic Alcohols Hydroxytyrosol and Tyrosol in the Human GI Tract Simulated by the In Vitro GIDM-Colon Model.

Authors:  Maria Eleni Sakavitsi; Annelies Breynaert; Theodora Nikou; Stef Lauwers; Luc Pieters; Nina Hermans; Maria Halabalaki
Journal:  Metabolites       Date:  2022-04-26

2.  Physicochemical properties, structure, and ameliorative effects of insoluble dietary fiber from tea on slow transit constipation.

Authors:  Xiaoli Bai; Yi He; Bingyan Quan; Ting Xia; Xianglong Zhang; Yongqi Wang; Yu Zheng; Min Wang
Journal:  Food Chem X       Date:  2022-05-21

3.  Novel Natural Products for Healthy Ageing from the Mediterranean Diet and Food Plants of Other Global Sources-The MediHealth Project.

Authors:  Birgit Waltenberger; Maria Halabalaki; Stefan Schwaiger; Nicolas Adamopoulos; Noureddine Allouche; Bernd L Fiebich; Nina Hermans; Pidder Jansen-Dürr; Victor Kesternich; Luc Pieters; Stefan Schönbichler; Alexios-Leandros Skaltsounis; Hung Tran; Ioannis P Trougakos; Alvaro Viljoen; Jean-Luc Wolfender; Christian Wolfrum; Nikos Xynos; Hermann Stuppner
Journal:  Molecules       Date:  2018-05-06       Impact factor: 4.411

4.  Compound Characterization and Metabolic Profile Elucidation after In Vitro Gastrointestinal and Hepatic Biotransformation of an Herniaria hirsuta Extract Using Unbiased Dynamic Metabolomic Data Analysis.

Authors:  Laura Peeters; Anastasia Van der Auwera; Charlie Beirnaert; Sebastiaan Bijttebier; Kris Laukens; Luc Pieters; Nina Hermans; Kenn Foubert
Journal:  Metabolites       Date:  2020-03-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.